TrialDiabetologia2019
Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program.
David R Matthews et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
52 papers cite it
this paperpooled ittrialcites it
TrialDiabetologia2019
David R Matthews et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.